Eltrombopag with or without Tacrolimus for relapsed/refractory acquired aplastic anaemia: a prospective randomized trial

This trial compared eltrombopag (EPAG)+tacrolimus and EPAG monotherapy in patients with refractory/relapsed acquired aplastic anaemia (AA). Patients with refractory/relapsed AA were randomly assigned to receive either EPAG+tacrolimus or EPAG monotherapy at a ratio of 2:1. Patient response, safety, c...

Descripción completa

Detalles Bibliográficos
Autores principales: Ji, Jiang, Wan, Ziqi, Ruan, Jing, Yang, Yuan, Hu, Qinglin, Chen, Zesong, Yang, Chen, Chen, Miao, Han, Bing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509202/
https://www.ncbi.nlm.nih.gov/pubmed/37726286
http://dx.doi.org/10.1038/s41408-023-00921-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509202/
https://www.ncbi.nlm.nih.gov/pubmed/37726286
http://dx.doi.org/10.1038/s41408-023-00921-8

Ejemplares similares